Advocacy

SDPA Announces 2026–27 Leadership Election Results

The Society of Dermatology Physician Associates (SDPA) is pleased to announce the results of the 2026–27 Leadership Elections. We extend our sincere congratulations to the newly elected leaders who will help guide the organization over the coming term, beginning July 1, 2026 and continuing to June 30, 2027.
These individuals were selected by their peers to represent the diverse voices and interests of SDPA members, and each brings a strong commitment to service, collaboration, and advancing the profession.

SDPA Statement on FDA Withdrawing Proposed Ban of Minors Using Sunlamps

The Society of Dermatology Physician Associates (SDPA) expresses its disappointment in the U.S. Food and Drug Administration’s (FDA) decision to withdraw its proposal to ban minors from using sunlamps.  

SDPA Statement on Topical Steroids

The Society of Dermatology Physician Assistants (SDPA) recognizes emerging evidence on potential adverse effects associated with prolonged topical corticosteroid use in managing chronic inflammatory dermatoses. These findings highlight the need for vigilant treatment planning to mitigate long-term risks. To prioritize patient safety and optimize outcomes, the SDPA advocates for routine assessment of cumulative steroid exposure as a cornerstone of patient care.

From the Hill: What the One Big Beautiful Bill Act Means for Dermatology PAs

Washington recently passed the wide-ranging One Big Beautiful Bill Act, a sweeping legislative package that touches everything from energy to tax reform.

Apremilast and IRA

The IRA’s drug price negotiations aim to lower costs but risk limiting patient access, treatment options, and future innovation. The SDPA urges policymakers to balance affordability with maintaining a broad range of therapies essential for individualized patient care.

Pharmacy Benefit Reform - New York S.1267-A

Pharmacy Benefit Reform Fails in 118th Congress New York S.1267-A Sets Precedent for States Moving Forward

SDPA Strengthens Advocacy and Public Relations Program with Key Leadership Appointments

SDPA Urges Action to Support Step-Therapy Reform Bill S.1267-A

Tell Congress to Recognize the High Quality of Care Delivered by PAs!

SDPA and other Healthcare Groups Applaud Filing of the Safe Step Act in the U.S House and Senate ​

SDPA Signs Letter Asking Congress to Include Medical Treatments in Mental Health Legislation

News Categories